Cargando…

Explore the Effect and Target of Liraglutide on Islet Function in Type 2 Diabetic Rats by miRNA Omics Technology

PURPOSE: To analyze the effect and potential therapeutic targets of liraglutide in type 2 diabetes through miRNA expression profiling. METHODS: Ten of 30 SPF Wistar rats, males at 4 weeks old, were randomly selected as the control group and given conventional feed, the other rats adopted high-sugar...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qiuyue, Xu, Yunsheng, Li, Jie, An, Wenrong, Luo, Dan, Huang, Chengcheng, Huang, Yanqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425186/
https://www.ncbi.nlm.nih.gov/pubmed/34511953
http://dx.doi.org/10.2147/DMSO.S325030
_version_ 1783749807028830208
author Guo, Qiuyue
Xu, Yunsheng
Li, Jie
An, Wenrong
Luo, Dan
Huang, Chengcheng
Huang, Yanqin
author_facet Guo, Qiuyue
Xu, Yunsheng
Li, Jie
An, Wenrong
Luo, Dan
Huang, Chengcheng
Huang, Yanqin
author_sort Guo, Qiuyue
collection PubMed
description PURPOSE: To analyze the effect and potential therapeutic targets of liraglutide in type 2 diabetes through miRNA expression profiling. METHODS: Ten of 30 SPF Wistar rats, males at 4 weeks old, were randomly selected as the control group and given conventional feed, the other rats adopted high-sugar and high-fat diet combined with an intraperitoneal injection of streptozotocin to establish a T2DM model. One unsuccessful rat was excluded, and the remaining rats were randomized to the model and the liraglutide group. Liraglutide group was subcutaneously injected with liraglutide 0.11 mg/kg for 8 weeks. The biochemical indicators and staining HE were detected. The expression of miRNA in pancreatic tissue was detected by miRNA sequencing. The intersection of miRNA difference was used to predict the target gene, then functional enrichment was performed to identify its possible biological functions and signal transduction paths. Finally, qRT-PCR was used to verify the results. RESULTS: Compared to the model group, the level of fasting blood glucose (FBG), glucagon and insulin resistance index (HOMA-IR) in the liraglutide group were significantly decreased, fasting insulin (FINS) and insulin sensitivity index (ISI) were increased. Nine differential miRNAs (miR-135a-5p, miR-144-5p, miR-21-3p, miR-215, miR-451-5p, miR-486, miR-122-5p, miR-181d-5p and miR-345-5p) were identified at the intersection through two miRNA sequencing. A total of 3359 related target gene predictions were obtained. GO and pathway analyses demonstrated that differentially expressed genes were closely related to cell proliferation, angiogenesis, and proteolysis. Significant signaling pathways included PI signaling system, autophagy, FoxO and HIF-1 signaling pathway. CONCLUSION: Liraglutide could improve islet function by regulating nine miRNAs, and the related signaling pathways included PI signaling system, autophagy, FoxO and HIF-1 signaling pathway. Our study provided the basis and direction for further exploring the molecular mechanism of liraglutide on T2DM.
format Online
Article
Text
id pubmed-8425186
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84251862021-09-09 Explore the Effect and Target of Liraglutide on Islet Function in Type 2 Diabetic Rats by miRNA Omics Technology Guo, Qiuyue Xu, Yunsheng Li, Jie An, Wenrong Luo, Dan Huang, Chengcheng Huang, Yanqin Diabetes Metab Syndr Obes Original Research PURPOSE: To analyze the effect and potential therapeutic targets of liraglutide in type 2 diabetes through miRNA expression profiling. METHODS: Ten of 30 SPF Wistar rats, males at 4 weeks old, were randomly selected as the control group and given conventional feed, the other rats adopted high-sugar and high-fat diet combined with an intraperitoneal injection of streptozotocin to establish a T2DM model. One unsuccessful rat was excluded, and the remaining rats were randomized to the model and the liraglutide group. Liraglutide group was subcutaneously injected with liraglutide 0.11 mg/kg for 8 weeks. The biochemical indicators and staining HE were detected. The expression of miRNA in pancreatic tissue was detected by miRNA sequencing. The intersection of miRNA difference was used to predict the target gene, then functional enrichment was performed to identify its possible biological functions and signal transduction paths. Finally, qRT-PCR was used to verify the results. RESULTS: Compared to the model group, the level of fasting blood glucose (FBG), glucagon and insulin resistance index (HOMA-IR) in the liraglutide group were significantly decreased, fasting insulin (FINS) and insulin sensitivity index (ISI) were increased. Nine differential miRNAs (miR-135a-5p, miR-144-5p, miR-21-3p, miR-215, miR-451-5p, miR-486, miR-122-5p, miR-181d-5p and miR-345-5p) were identified at the intersection through two miRNA sequencing. A total of 3359 related target gene predictions were obtained. GO and pathway analyses demonstrated that differentially expressed genes were closely related to cell proliferation, angiogenesis, and proteolysis. Significant signaling pathways included PI signaling system, autophagy, FoxO and HIF-1 signaling pathway. CONCLUSION: Liraglutide could improve islet function by regulating nine miRNAs, and the related signaling pathways included PI signaling system, autophagy, FoxO and HIF-1 signaling pathway. Our study provided the basis and direction for further exploring the molecular mechanism of liraglutide on T2DM. Dove 2021-09-01 /pmc/articles/PMC8425186/ /pubmed/34511953 http://dx.doi.org/10.2147/DMSO.S325030 Text en © 2021 Guo et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Guo, Qiuyue
Xu, Yunsheng
Li, Jie
An, Wenrong
Luo, Dan
Huang, Chengcheng
Huang, Yanqin
Explore the Effect and Target of Liraglutide on Islet Function in Type 2 Diabetic Rats by miRNA Omics Technology
title Explore the Effect and Target of Liraglutide on Islet Function in Type 2 Diabetic Rats by miRNA Omics Technology
title_full Explore the Effect and Target of Liraglutide on Islet Function in Type 2 Diabetic Rats by miRNA Omics Technology
title_fullStr Explore the Effect and Target of Liraglutide on Islet Function in Type 2 Diabetic Rats by miRNA Omics Technology
title_full_unstemmed Explore the Effect and Target of Liraglutide on Islet Function in Type 2 Diabetic Rats by miRNA Omics Technology
title_short Explore the Effect and Target of Liraglutide on Islet Function in Type 2 Diabetic Rats by miRNA Omics Technology
title_sort explore the effect and target of liraglutide on islet function in type 2 diabetic rats by mirna omics technology
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425186/
https://www.ncbi.nlm.nih.gov/pubmed/34511953
http://dx.doi.org/10.2147/DMSO.S325030
work_keys_str_mv AT guoqiuyue exploretheeffectandtargetofliraglutideonisletfunctionintype2diabeticratsbymirnaomicstechnology
AT xuyunsheng exploretheeffectandtargetofliraglutideonisletfunctionintype2diabeticratsbymirnaomicstechnology
AT lijie exploretheeffectandtargetofliraglutideonisletfunctionintype2diabeticratsbymirnaomicstechnology
AT anwenrong exploretheeffectandtargetofliraglutideonisletfunctionintype2diabeticratsbymirnaomicstechnology
AT luodan exploretheeffectandtargetofliraglutideonisletfunctionintype2diabeticratsbymirnaomicstechnology
AT huangchengcheng exploretheeffectandtargetofliraglutideonisletfunctionintype2diabeticratsbymirnaomicstechnology
AT huangyanqin exploretheeffectandtargetofliraglutideonisletfunctionintype2diabeticratsbymirnaomicstechnology